Volume 28, Number 11—November 2022
Dispatch
Seroincidence of Enteric Fever, Juba, South Sudan
Table 2
Age group, y | Seroincidence, cases/100 person-years (95% CI) | 2-year cumulative incidence, % (IQR) | 4-year cumulative incidence, % (IQR) |
---|---|---|---|
1–3 | 42.5 (38.0–59.0) | 53.6 (44.5–74.9) | 78.5 (69.2–93.7) |
4–6 | 32.1 (29.7–40.1) | 56.6 (34.7–68.5) | 81.2 (57.4–90.0) |
7–9 | 29.2 (27.3–35.6) | 49.3 (39.9–59.1) | 74.3 (63.8–83.3) |
10–14 | 24.8 (23.6–28.8) | 45.1 (30.9–58.4) | 69.9 (52.2–82.7) |
15–24 | 28.3 (24.7–41.9) | 42.8 (27.2–61.6) | 67.3 (47.0–85.3) |
25–34 | 28.8 (26.7–35.9) | 51.7 (35.7–66.5) | 76.7 (58.6–88.8) |
35–44 | 40.8 (36.0–58.5) | 57.5 (49.8–69.5) | 82.0 (74.8–90.7) |
>45 |
34.0 (30.6–46.2) |
53.0 (40.9–69.1) |
77.9 (65.1–90.5) |
Overall | 29.8 (27.6–32.2) | 48.9 (31.9–64.3) | 73.8 (53.7–87.3) |
*IQR, interquartile range.
Page created: October 13, 2022
Page updated: October 24, 2022
Page reviewed: October 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.